Dual mechanism inhibitors for the treatment of disease

Details for Australian Patent Application No. 2010241996 (hide)

Owner Aerie Pharmaceuticals, Inc.

Inventors Delong, Mitchell A.; Sturdivant, Jill Marie; Royalty, Susan M.

Agent Griffith Hack

Pub. Number AU-A-2010241996

PCT Pub. Number WO2010/126626

Priority 61/174,672 01.05.09 US

Filing date 27 January 2010

Wipo publication date 4 November 2010

International Classifications

C07D 217/00 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 27/00 (2006.01) Drugs for disorders of the senses

C07C 237/00 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

24 November 2011 PCT application entered the National Phase

  PCT publication WO2010/126626 Priority application(s): WO2010/126626

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010242006-Hardware encrypting storage device with physically separable key storage device

2010241992-Injection syringe plunger valve assembly